About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Monoclonal Antibodies
in Immunodiagnosis
and Immunotherapy

Editor: Zenon Steplewski

ISSN: • Published Bimonthly • Online ISSN: 2167-9436

Current Volume: 33

For Authors

  • Manuscript Submissions
  • NIH/HHMI Wellcome Trust Policies
  • Self-Archiving Policy
  • Open Access Policy
  • Manuscript Submissions

    Manuscripts must be submitted online using the following URL http://mc.manuscriptcentral.com/mab

    Copyright Agreement

    Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, except in the form of an abstract.  Prior abstract publications should be described in the form of a footnote to the article title.  Published manuscripts become the sole property of the Journal and will be copyrighted by Mary Ann Liebert, Inc.  

    Upon acceptance of any manuscript, EACH author listed on a paper will receive a follow-up email with instructions to complete the online Copyright Agreement form.  It is critical to ensure the accuracy of ALL authors’ email addresses when uploading submissions to Manuscript Central to ensure the proper delivery of all email communications, particularly the Copyright Agreement.


    Monoclonal Antibodies in Immunodiagnosis and Immunotherapy (formerly Hybridoma) will publish both full and short communications. Full communications should be prepared in the format described below; short communications do not need compartmentalization and should be limited to a maximum of two tables or two figures or one of each.  Authors will be allowed to indicate one reviewer who should be excluded from review of their manuscript. The Journal also includes MONOCLONAL ANTIBODIES. This section provides prompt publication of current information on new hybrid cell lines, methodology, and other information arising from the use of monoclonal antibodies.

    MAb Forms: If you need to download the MAb form, a template may be found at http://www.liebertpub.com/media/pdf/mabform.pdf.

    To help defray the cost of processing, the Publisher requests that page charges of $65 per typeset page be paid by all authors who have funds available from research grants or from their institutions. It should be noted that ability to pay page charges is not a prerequisite for publication in the Journal.

    Be sure these instructions are followed exactly.

    Prepare manuscripts double-spaced in Microsoft Word. Leave ample margins on the sides, top, and bottom of the page. TABLES AND ILLUSTRATIONS.  Prepare each table with its title on a separate page. Use Arabic numerals to number tables. Remember, each table must stand alone, i.e., contain all necessary information in the caption, and the table itself must be understood independently of the text. Details of experimental conditions should be included in the table footnotes. Information that appears in the text should not be repeated in tables, and tables should not contain data that can be given in the text in one or two sentences. All illustrations should be numbered and labeled with the first author’s name. A legend should be supplied for each illustration, and all legends numbered consecutively and provided (double-spaced) on a separate page. Figures should be numbered in the order cited in the text. Images should not show the name of the manufacturer. Please keep in mind that the figures will be reduced, so please do not submit large figures/graphs that contain small type, as the text within the figure will not be readable after reduction.

    Please follow these instructions when submitting figures:              

    •  Do not include any illustrations as part of your text file.
    •  Do not prepare any figures in Word as they are not workable.
    •  Line illustrations must be submitted at a minimum of 900.
    •  Halftones and color photos should be submitted at a minimum of 300 DPI.
    •  PowerPoint of Excel files cannot be uploaded.
    •  Save art as either TIFF or EPS files.  Do NOT submit JPEG  files.

    You will be given directions on how to correct any files which do not pass.



    Converting Word or Excel files: Perhaps the best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:

    All files should be scanned at 100% size.
    300 dpi
    Final color mode: cmyk
    save file as: .tif or .eps


    If you need directions on how to convert a Power Point slide to acceptable format go to http://www.liebertpub.com/MEDIA/pdf/ppconvert.pdf

    All authors are expected to disclose any institutional or commercial affiliations that might pose a conflict of interest regarding the publication of a manuscript. Institutional affiliations, as indicated on the title page, should include all corporate affiliations and any funding sources that support the work. Other types of affiliation, including consultantships, honoraria, stock ownership, equity interests, arrangements regarding patents, or other vested interests should be disclosed in the Acknowledgments section.

    All references must be cited in text. (1) Cite references within the text by an Arabic number within parentheses or brackets. Brackets may be used when parentheses are to be reserved for numbers for equations. (2) List references by numbers (1., 2., etc.) in the order in which they appear in the text. Type double spaced, although separated from each other by one line of space. (3) Use Chemical Abstracts format for references. For journal citations: (1) surname of author(s), initials, (2) paper title, (3) journal, (4) volume number, (5) first and last page of citation, and (6) year in parentheses. For book citations: (1) surname of author(s), initials, (2) title of book, (3) editor of book (if applicable), (4) edition of book (if applicable), (5) publisher, (6) city of publication, (7) year of publication (not in parentheses), and (8) first and last page reference (if applicable). For patents: (1) country of original registration, (2) patent number, (3) month, day, and year of issuance. Follow the style of these examples:

    Journal paper: Ahmed I, Piepkorn M, and Goldgar DE: HMB-45 staining of dysplastic melanocytic nevi. J Cutan Pathol 1991;18:257-260.

    Book: Walsh JH: Gastrointestinal hormones. In: Physiology of the Gastrointestinal Tract, 2nd ed. Johnson L, Christensen J, Jackson M, Jacobson E, and Walsh JH (Eds.). Raven, New York, 1987, pp. 181-254.

    Harlow E, and Lane D: Antibodies: A Laboratory Manual Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1988.

    When data from an unpublished source are given, supply complete information, e.g., researcher's name and location. If work is in press, give journal in which it is to be published or publisher.

    The author must obtain permission to reproduce figures, tables, and text from previously published material. Written permission must be obtained from the original copyright holder (generally the publisher, not the author or editor) of the journal or book concerned. An appropriate credit line should be included in the figure legend or table footnote, and full publication information should be included in the reference list. Written permission must be obtained from the author of any unpublished material cited from other laboratories, and should accompany the manuscript. All permission listings must be shown in manuscript-they cannot be entered on proofs.

    Once a paper is accepted, changes in authorship in page proofs are NOT permitted under any circumstance.

    It is the Journal’s policy that a manuscript has only ONE corresponding author listed on a paper.  This designation should be determined at the time of submission.  Additions to corresponding authors are not permitted after acceptance or in page proofs.

    Page proofs will be sent to the (one) corresponding author as designated when the manuscript was uploaded to Manuscript Central.  It is the corresponding author’s responsibility to share the page proofs with co-authors and to coordinate all authors’ corrections into one proof.  The Publisher will not accept corrections from multiple authors.

    Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.

    The Journal is published by Mary Ann Liebert, Inc., publishers, 140 Huguenot Street, New Rochelle, NY 10801-5215.  Telephone: (914) 740–2100; fax: (914) 740–2101.  E-mail: info@liebertpub.com, web site:  www.liebertpub.com/mab

  • NIH/HHMI Wellcome Trust Policies

    NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

  • Self-Archiving Policy

    Mary Ann Liebert, Inc. is a "blue" publisher (as defined by Sherpa), as we allow self-archiving of post-print (ie final draft post-refereeing) or publisher's version/PDF.

    In assigning Mary Ann Liebert, Inc. copyright, the author retains the right to deposit such a 'post-print' on their own website, or on their institution's intranet, or within the Institutional Repository of their institution or company of employment, on the following condition, and with the following acknowledgement:

    This is a copy of an article published in the [JOURNAL TITLE] © [year of publication] [copyright Mary Ann Liebert, Inc.]; [JOURNAL TITLE] is available online at: http://online.liebertpub.com.

    Authors may also deposit this version on his/her funder's or funder's designated repository at the funder's request or as a result of a legal obligation, provided it is not made publicly available until 12 months after official publication.

  • Open Access Policy

    Choose Liebert Open Access Option!

    Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) Option.

    Your investment guarantees:

    • Immediate, unrestricted global access in 170 countries
    • Maximum visibility for increased readers, citations, and downloads
    • Targeted email announcement highlighting your article to thousands of thought-leaders in your field
    • Rapid, rigorous peer-review and editorial attention
    • Fast Track online-ahead-of-print publication
    • Immediate upload to PubMed Central and other internationally recognized repositories*
    • Recognition on online Table of Contents with exclusive OA icon
    • Compliance with OA funding mandates with no embargo period
    • Savings on future OA article publication
    • Complimentary membership in AuthorCite®, the author services platform exclusively licensed by Mary Ann Liebert, Inc. that delivers the tools you need to maximize your professional impact.

    These valuable benefits are included with a one-time article processing charge (APC). APC charge varies based on journal, membership, and subsequent submissions.

    Contact openaccess@liebertpub.com for questions on article Open Access options. 

     *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


    Is your Institution a member of the Liebert Author Advocacy Program?

    The Liebert Author Advocacy Program (LAAP) provides valuable membership benefits for OA publication to institutional and funding organizations, and supports global funding mandates.  Authors who are affiliated with LAAP member institutions receive all the valuable benefits of Liebert OA article publication, and more.

    For details, and to recommend institutional membership visit: www.authoradvocacy.com or contact laap@liebertpub.com 




The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    AIDS Research and Human Retroviruses

    AIDS Research and Human Retroviruses

    The leading journal in the field for over 25 years, providing the latest developments and research advances in HIV/AIDS and other retroviruses leading to improvements in translational medicine for optimal treatment outcomes.

    Cancer Biotherapy and Radiopharmaceuticals

    Cancer Biotherapy and Radiopharmaceuticals

    The established journal with over 25 years of peer-reviewed papers on new and innovative investigations of methods to improve cancer therapy. The Journal focuses on advancements in radioimmunotherapy and radiopharmaceuticals.

    ASSAY and Drug Development Technologies

    ASSAY and Drug Development Technologies

    This authoritative, rapidly peer-reviewed journal features original articles, application-oriented technology reviews, and reports in methodology and technology application.

    DNA and Cell Biology

    DNA and Cell Biology

    Combining mechanistic and clinical studies from multiple systems in a single resource, the Journal delivers authoritative, peer-reviewed reporting on the latest research in the field of molecular biology.

    Human Gene Therapy

    Human Gene Therapy

    The definitive rapid-publication journal covering all aspects of gene therapy through original investigations into the transfer and expression of genes in mammals, with in-depth coverage of DNA, RNA, and cell therapies.

    Viral Immunology

    Viral Immunology

    The only journal reporting on all aspects of the rapidly growing field of viral immunology, with comprehensive coverage of immune responses to viral infections from basic mechanisms to clinical applications.

Browse All Publications »